Erlotinib Active Not Recruiting Phase 2 Trials for Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 / Metastatic Squamous Cell Carcinoma of the Hypopharynx / Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 / Recurrent Hypopharyngeal Squamous Cell Carcinoma / Recurrent Oral Cavity Squamous Cell Carcinoma / Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 / Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 / Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 / Recurrent Laryngeal Squamous Cell Carcinoma / Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 / Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 / Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 / Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 / Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 / Metastatic Squamous Cell Carcinoma of the Oropharynx / Metastatic Squamous Cell Carcinoma of the Oral Cavity / Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 / Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 / Recurrent Oropharyngeal Squamous Cell Carcinoma / Metastatic Squamous Cell Carcinoma of the Larynx / Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 / Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 / Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 / Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 / Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01064479Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
NCT01927744Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
NCT00076310OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer